Big fish to eat shrimp!

Roche, founded in 1896, is the world's largest innovation company in drug development and disease Diagnostics and a leader in the field of anti-tumor. and foundation Dentistry (FM) We have previously introduced, the use of genetic diagnostics, for cancer patients to determine the most accurate treatment options, has been to Google Ventures and Bill Gates contributed 100 million of dollars in financing. According to Forbes, Roche plans to use 10.3 billion U.S. dollars as a stepping stone, accounting for 56.3%, become the latter's largest shareholder, a share of about 50 U.S. dollars, than the FM market share price higher.

Next, Roche intends to promote the diagnosis of FM outside the United States, while educating doctors groups, so that foreign medical and domestic production linkage. In addition, they intend to give FM1.5 billions of dollars in research and development funds.

In the company's operation, FM is still independent, and Roche will only arrange 3 directors into the FM board. But FM shares have fallen 32% since the IPO in 2013, while the S&P has risen 20%. Shareholders also have their own concerns, such as the lack of cooperation with insurance or pharmaceutical companies, and the purchase of DNA sequenccer using Illumina. However, the development of FM, Roche is a very good practice channel.

Roche Group has been known for its activism and innovation in the fields of biotechnology and pharmaceutical research, and one of the directions is the recent hot personalized medical care. Last November, Roche invested 860 million yuan to build Shanghai Innovation Center, the Fourth Innovation Center in the world.

If you have an idea for cancer diagnosis or genetic diagnosis, or if you know a big fish like Roche, you might as well send an email to chat.